Associated Papers
Clinically Actionable Hypertrophic Cardiomyopathy Genes in South Asian Indian Patients.
Rao VJ et al.
Journal of the American Heart Association, 2025
41128141 (PubMed )
Supplement: JAH3-14-e042036-s001.pdf
Significance of α-Myosin Heavy Chain (MYH6) Variants in Hypoplastic Left Heart Syndrome and Related Cardiovascular Diseases.
Anfinson M et al.
Journal of Cardiovascular Development and Disease, 2022
Altered myocyte contractility and calcium homeostasis in alpha-myosin heavy chain point mutations linked to familial dilated cardiomyopathy.
Klos M et al.
Archives of Biochemistry and Biophysics, 2017
Role of Titin Missense Variants in Dilated Cardiomyopathy.
Begay RL et al.
Journal of the American Heart Association, 2015
Poor prognosis of rare sarcomeric gene variants in patients with dilated cardiomyopathy.
Merlo M et al.
Clinical and Translational Science, 2013
Global DNA methylation and transcriptional analyses of human ESC-derived cardiomyocytes.
Gu Y et al.
Protein & Cell, 2013
Cardiac alpha-myosin (MYH6) is the predominant sarcomeric disease gene for familial atrial septal defects.
Posch MG et al.
Plos One, 2011
Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy.
Carniel E et al.
Circulation, 2005
Select a paper to view details